Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-000426
Filing Date
2025-01-15
Accepted
2025-01-15 11:36:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27707
2 filename2.txt TEXT-EXTRACT 1193
  Complete submission text file 0000000000-25-000426.txt   40405
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filed for) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-284233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)